Chris P. Miller

Person

Hingham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Estrogen receptor-modulating compounds
- Patent number 12,018,019
- Issue date Jun 25, 2024
- Radius Pharmaceuticals, Inc.
- Chris Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer nuclear hormone receptor-targeting compounds
- Patent number 12,006,314
- Issue date Jun 11, 2024
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer nuclear hormone receptor-targeting compounds
- Patent number 11,952,349
- Issue date Apr 9, 2024
- NUVATION BIO INC.
- Son Minh Pham
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer nuclear hormone receptor-targeting compounds
- Patent number 11,834,458
- Issue date Dec 5, 2023
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AR+ breast cancer treatment methods
- Patent number 11,771,682
- Issue date Oct 3, 2023
- Ellipses Pharma Ltd.
- Gary Hattersley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Distributed recovery of server information
- Patent number 11,599,427
- Issue date Mar 7, 2023
- Hitachi Vantara LLC
- Ngale Clark
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Heterocyclic compounds as BET inhibitors
- Patent number 11,584,756
- Issue date Feb 21, 2023
- NUVATION BIO INC.
- Son Minh Pham
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Estrogen receptor-modulating compounds
- Patent number 11,384,068
- Issue date Jul 12, 2022
- Radius Pharmaceuticals, Inc.
- Chris Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating Parkinson's disease
- Patent number 11,091,507
- Issue date Aug 17, 2021
- AbbVie Inc.
- Brian P. Enright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbidopa and L-dopa prodrugs and methods of use
- Patent number 10,174,061
- Issue date Jan 8, 2019
- AbbVie Inc.
- Benoit Cardinal-David
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor modulators
- Patent number 9,920,044
- Issue date Mar 20, 2018
- RADIUS PHARMACEUTICALS, INC.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbidopa and L-dopa prodrugs and methods of use
- Patent number 9,446,059
- Issue date Sep 20, 2016
- AbbVie Inc.
- Benoit Cardinal-David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective androgen receptor modulators
- Patent number 9,133,182
- Issue date Sep 15, 2015
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor modulators
- Patent number 8,987,319
- Issue date Mar 24, 2015
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor modulators
- Patent number 8,642,632
- Issue date Feb 4, 2014
- Radius Health, Inc.
- Chris P. Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective androgen receptor modulators
- Patent number 8,629,167
- Issue date Jan 14, 2014
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor modulators
- Patent number 8,455,525
- Issue date Jun 4, 2013
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor modulators
- Patent number 8,268,872
- Issue date Sep 18, 2012
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective androgen receptor modulators
- Patent number 8,067,448
- Issue date Nov 29, 2011
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20240352027
- Publication date Oct 24, 2024
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR-MODULATING COMPOUNDS
- Publication number 20240308986
- Publication date Sep 19, 2024
- RADIUS PHARMACEUTICALS, INC.
- Chris MILLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AR+BREAST CANCER TREATMENT METHODS
- Publication number 20240207234
- Publication date Jun 27, 2024
- ELLIPSES PHARMA LTD
- Gary Hattersley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE
- Publication number 20240024338
- Publication date Jan 25, 2024
- ABBVIE INC.
- Benoit Cardinal-David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
- Publication number 20230339964
- Publication date Oct 26, 2023
- NUVATION BIO INC.
- Son Minh PHAM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
- Publication number 20230174545
- Publication date Jun 8, 2023
- NUVATION BIO INC.
- Son Minh PHAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING PARKINSON'S DISEASE
- Publication number 20230106081
- Publication date Apr 6, 2023
- ABBVIE INC.
- Benoit CARDINAL-DAVID
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATING CANCERS WITH A CYCLIN-DEPENDENT KINASE INHIBITOR
- Publication number 20230000876
- Publication date Jan 5, 2023
- NUVATION BIO INC.
- Teeru BIHANI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20220380364
- Publication date Dec 1, 2022
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20220340587
- Publication date Oct 27, 2022
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR-MODULATING COMPOUNDS
- Publication number 20220332704
- Publication date Oct 20, 2022
- RADIUS PHARMACEUTICALS, INC.
- Chris MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR-MODULATING COMPOUNDS
- Publication number 20220281875
- Publication date Sep 8, 2022
- Chris P. MILLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS
- Publication number 20220273659
- Publication date Sep 1, 2022
- NUVATION BIO INC.
- Son Minh PHAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING PARKINSON'S DISEASE
- Publication number 20220153765
- Publication date May 19, 2022
- ABBVIE INC.
- Benoit Cardinal-David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20210214316
- Publication date Jul 15, 2021
- NUVATION BIO INC.
- Son Minh Pham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DISTRIBUTED RECOVERY OF SERVER INFORMATION
- Publication number 20210200648
- Publication date Jul 1, 2021
- Hitachi Vantara LLC
- Ngale CLARK
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
- Publication number 20210002293
- Publication date Jan 7, 2021
- NUVATION BIO INC.
- Son Minh PHAM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ESTROGEN RECEPTOR-MODULATING COMPOUNDS
- Publication number 20200347032
- Publication date Nov 5, 2020
- Chris Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARBIDOPA PRODRUGS
- Publication number 20200262852
- Publication date Aug 20, 2020
- ABBVIE INC.
- Benoit Cardinal-David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AR+ BREAST CANCER TREATMENT METHODS
- Publication number 20200171008
- Publication date Jun 4, 2020
- RADIUS HEALTH, INC.
- Gary HATTERSLEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Carbidopa and L-Dopa Prodrugs and Methods of use
- Publication number 20180079762
- Publication date Mar 22, 2018
- ABBVIE INC.
- Benoit Cardinal-David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AR+ BREAST CANCER TREATMENT METHODS
- Publication number 20170368036
- Publication date Dec 28, 2017
- RADIUS HEALTH, INC.
- Gary HATTERSLEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective androgen receptor modulators
- Publication number 20170121285
- Publication date May 4, 2017
- RADIUS HEALTH, INC.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Carbidopa And L-Dopa Prodrugs And Methods Of Use
- Publication number 20160362431
- Publication date Dec 15, 2016
- ABBVIE, INC.
- Benoit CARDINAL-DAVID
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Carbidopa and L-Dopa Prodrugs and Methods of Use
- Publication number 20160106765
- Publication date Apr 21, 2016
- ABBVIE INC.
- Benoit CARDINAL-DAVID
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE ANDROGEN RECEPTOR MODULATORS
- Publication number 20150322059
- Publication date Nov 12, 2015
- RADIUS HEALTH, INC.
- Chris P. MILLER
- G01 - MEASURING TESTING
Information Patent Application
SELECTIVE ANDROGEN RECEPTOR MODULATORS
- Publication number 20150266821
- Publication date Sep 24, 2015
- RADIUS HEALTH, INC.
- Chris P. MILLER
- G01 - MEASURING TESTING
Information Patent Application
Selective Androgen Receptor Modulators
- Publication number 20130116288
- Publication date May 9, 2013
- Radius Health, Inc.
- Chris P. Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective Androgen Receptor Modulators
- Publication number 20130041007
- Publication date Feb 14, 2013
- Chris P. Miller
- G01 - MEASURING TESTING
Information Patent Application
Selective Androgen Receptor Modulators
- Publication number 20120004270
- Publication date Jan 5, 2012
- Radius Health, Inc.
- Chris P. Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Chris P. Miller

Person

Patents Grantslast 30 patents

Estrogen receptor-modulating compounds

Anti-cancer nuclear hormone receptor-targeting compounds

Anti-cancer nuclear hormone receptor-targeting compounds

Anti-cancer nuclear hormone receptor-targeting compounds

AR+ breast cancer treatment methods

Distributed recovery of server information

Heterocyclic compounds as BET inhibitors

Estrogen receptor-modulating compounds

Methods of treating Parkinson's disease

Carbidopa and L-dopa prodrugs and methods of use

Selective androgen receptor modulators

Carbidopa and L-dopa prodrugs and methods of use

Selective androgen receptor modulators

Selective androgen receptor modulators

Selective androgen receptor modulators

Selective androgen receptor modulators

Selective androgen receptor modulators

Selective androgen receptor modulators

Selective androgen receptor modulators

Patents Applicationslast 30 patents

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

AR+BREAST CANCER TREATMENT METHODS

CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE

HETEROCYCLIC COMPOUNDS AS BET INHIBITORS

HETEROCYCLIC COMPOUNDS AS BET INHIBITORS

METHODS OF TREATING PARKINSON'S DISEASE

TREATING CANCERS WITH A CYCLIN-DEPENDENT KINASE INHIBITOR

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

METHODS OF TREATING PARKINSON'S DISEASE

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

DISTRIBUTED RECOVERY OF SERVER INFORMATION

HETEROCYCLIC COMPOUNDS AS BET INHIBITORS

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

CARBIDOPA PRODRUGS

AR+ BREAST CANCER TREATMENT METHODS

Carbidopa and L-Dopa Prodrugs and Methods of use

AR+ BREAST CANCER TREATMENT METHODS

Selective androgen receptor modulators

Carbidopa And L-Dopa Prodrugs And Methods Of Use

Carbidopa and L-Dopa Prodrugs and Methods of Use

SELECTIVE ANDROGEN RECEPTOR MODULATORS

SELECTIVE ANDROGEN RECEPTOR MODULATORS

Selective Androgen Receptor Modulators

Selective Androgen Receptor Modulators

Selective Androgen Receptor Modulators